Preparation of gold-palladium alloy loaded alpha-bromo-cinnamyl aldehyde nano antibacterial agent

The nano-anti-anti-bromocinnamaldehyde nanoant is activated by gold-palladium alloy-loaded α-bromocinnamaldehyde and release α-bromocinnamaldehyde in an acidic environment. Combined with photothermal therapy, the problem of hindered antibiotic efficacy is solved, and efficient removal of bacteria and promotion is achieved. Healing effect.

CN118976119AInactive Publication Date: 2024-11-19HOSPITAL OF STOMATOLOGY GUANGZHOU MEDICAL UNIVERSITY (YANGCHENG HOSPITAL OF GUANGZHOU MEDICAL UNIVERSITY)
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411046136.6
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-01
Publication Date
2024-11-19
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

The efficacy of existing antibiotics is hindered by multi-drug-resistant bacteria and bacterial biofilms. It is difficult to develop new antibiotics, and the bactericidal effect of nanoenzymes in the infected environment is affected by glutathione, making it difficult to effectively remove bacteria.

Method used

Using gold-palladium alloy-loaded α-bromocinnamaldehyde nanoant, ROS is generated by activate the enzyme activity of gold-palladium alloy nanoparticles in an acidic environment by forming imine bonds, and release α-bromocinnamaldehyde to eliminate glutathione. Synergistic photothermal therapy enhances sterilization effect.

Benefits of technology

It significantly improves the catalytic activity and bactericidal efficiency of nanoenzymes, can effectively remove bacteria in an acidic environment, promote infected wound healing, and reduce bacterial drug resistance.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118976119A_ABST
    Figure CN118976119A_ABST
Patent Text Reader

Abstract

The invention discloses a preparation method of a gold-palladium alloy loaded alpha-bromo-cinnamyl aldehyde nano antibacterial agent, and relates to the technical field of antibacterial agents. The preparation method comprises the following steps: preparing an eight-foot-shaped gold-palladium alloy nanoparticle powder sample, modifying the surfaces of gold-palladium alloy nanoparticles by using an amino polyethylene glycol surface diluent, adding alpha-bromocinnamyl aldehyde, reacting, dialyzing, washing and centrifuging to obtain the gold-palladium alloy loaded alpha-bromocinnamyl aldehyde nano antibacterial agent. According to the invention, the specific surface area of the gold-palladium alloy nano-particles is greatly increased, the surface catalytic sites are increased, and the catalytic activity of the nano-enzyme is improved. After entering an infected wound in an acid environment, the gold-palladium alloy loaded alpha-bromo-cinnamyl aldehyde nano antibacterial agent can cooperate with the multi-enzyme activity and mild photo-thermal effect of gold-palladium alloy nano particles, the antibacterial effect of alpha-bromo-cinnamyl aldehyde and the removal effect of glutathione by adjusting the change of the pH value of the environment, so that bacteria are effectively removed, and the wound healing effect is improved. The healing of bacterial infection wounds is promoted.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of antibacterial agents, in particular to a method for preparing a gold-palladium alloy-loaded alpha-bromocinnamaldehyde nano antibacterial agent. Background Art

[0002] Pathogens are a deadly threat to public health. According to statistics, more than 700,000 people die from bacterial infections worldwide each year. Since the first discovery of penicillin in 1928, various antibiotics have been developed and applied one after another. It can be said that in the antibiotic era, antibiotics are regarded as the gold standard for treating bacterial infections. However, with the irrational and excessive use of antibiotics, multidrug-resistant bacteria have changed at the genetic level, such as methicillin-resistant Staphylococcus aureus, carbapenem-resistant Escherichia coli, and Enterobacterium producing extended-spectrum β-lactamases. In addition, bacteria will aggregate and generate extracellular polymer matrices to form biofilms. These biofilm matrices serve as a protective barrier for bacteria, further weakening the effect of antibiotics by reducing the penetration of antibiotics. The existence of these multidrug-resistant bacteria and bacterial biofilms poses a huge challenge to the efficacy of antibiotics. In addition, the research and development process of new antibiotics is cumbersome and difficult, and the benefits are declining year by year. There is no doubt that in today's post-antibiotic era, facing the increasingly rampant super bacteria and the infectious diseases they cause, it is urgent to develop and utilize an efficient and safe antibiotic-free treatment plan.

[0003] Nanozymes are a class of nanomaterials that can mimic the catalytic activity of natural enzymes. Compared with natural enzymes, these artificial enzymes have the advantages of low production and storage costs, high stability, and adjustable catalytic activity. Gold, as a precious metal, has a variety of enzyme-like catalytic activities at the nanoscale, such as peroxidase, oxidase, catalase, and glucose oxidase activities. Therefore, gold nanomaterials can act as artificial enzymes and are used for anti-cancer, anti-bacterial, and anti-inflammatory purposes. In the field of antibacterial, nanozymes mainly rely on their peroxidase and / or oxidase activities to produce various reactive oxygen species (ROS) to kill bacteria. ROS such as hydroxyl radicals and singlet oxygen can exert oxidative stress on bacteria, effectively destroy bacterial membranes, cause the contents to flow out, and eventually die. In addition, this mode of action can greatly reduce the occurrence of bacterial resistance. The enzyme-like catalytic activity of nanozymes is a key factor in determining their efficacy.

[0004] In addition to the inherent physical and chemical properties of nanozymes, the infection site where the bacteria are located is also worthy of attention. Glutathione is a reducing agent, and its level will increase in the microenvironment of bacterial infection, thereby quenching reactive oxygen and reducing the bactericidal effect of nanozymes. Therefore, how to effectively reduce glutathione in the infection environment is an important means to improve the antibacterial efficacy mediated by nanozymes. Summary of the invention

[0005] The purpose of the present invention is to provide a method for preparing a gold-palladium alloy-loaded α-bromocinnamaldehyde nano antibacterial agent to solve the problems raised in the background technology.

[0006] To achieve the above object, the present invention provides the following technical solutions:

[0007] A preparation method of a gold-palladium alloy-loaded α-bromocinnamaldehyde nano antibacterial agent, the specific steps are as follows:

[0008] S1. Preheat the cationic surfactant aqueous solution at 70°C for 10 minutes, add the HAuCl4 / K2PdCl6 mixed solution, and homogenize for 3 minutes; add the reducing agent, and let it stand for reaction in a 70°C water bath for 2 hours. After the reaction is completed, centrifuge, wash with deionized water, and vacuum dry to obtain a gold-palladium alloy nanoparticle powder sample;

[0009] It should be noted that after gold and palladium form a gold-palladium alloy, the catalytic activity of multi-metal nanozymes is significantly improved compared to single-metal nanozymes due to the synergistic effect between metals. In addition, precious metal nanomaterials are excellent photothermal converters, which can achieve efficient photothermal therapy and photothermally enhanced cascade catalytic efficiency.

[0010] S2. Disperse the gold-palladium alloy nanoparticle powder sample in deionized water to obtain a gold-palladium alloy nanoparticle dispersion; slowly add the polyethylene glycol modifier aqueous solution to the gold-palladium alloy nanoparticle dispersion, ultrasonicate for 30 minutes, stir at room temperature for 12 hours, collect the lower precipitate by centrifugation, wash the precipitate with deionized water, disperse the precipitate in anhydrous ethanol with a pH of 8-9, add α-bromocinnamaldehyde while stirring, react at 60°C for 12 hours, dialyze, wash and centrifuge to obtain a gold-palladium alloy-loaded α-bromocinnamaldehyde nano-antibacterial agent.

[0011] It should be noted that octapod-shaped gold-palladium alloy nanoparticles with a large specific surface area were synthesized by a seedless method, and polyethylene glycol was used to modify them with amino groups, so that a large number of amino groups were obtained on the surface of the gold-palladium alloy nanoparticles. The amino groups on the amino-modified gold-palladium alloy nanoparticles and the aldehyde groups on α-bromocinnamaldehyde form imine bonds under alkaline conditions to form gold-palladium alloy-loaded α-bromocinnamaldehyde nanoantibacterial agents. When the gold-palladium alloy-loaded α-bromocinnamaldehyde nanoantibacterial agent enters the infected wound, on the one hand, the enzyme activity of the gold-palladium alloy nanoparticles is activated under weak acid conditions, producing a large amount of ROS to eliminate bacteria. On the other hand, the acidic pH causes the acid-sensitive imine bonds to break, releasing the loaded α-bromocinnamaldehyde to clear glutathione.

[0012] Furthermore, the gold-palladium alloy nanoparticles are in an octapod shape with a large specific surface area, and the particle size of the gold-palladium alloy nanoparticles is 60-80 nm.

[0013] It should be noted that nanozyme is a heterogeneous catalyst, which mainly relies on the atoms on its surface to play a catalytic role. Therefore, a larger specific surface area means that more surface catalytic sites can be obtained, thereby improving the catalytic activity of the nanozyme. By regulating the morphology of gold-palladium alloy nanoparticles, multi-branched octapod-shaped gold-palladium alloy nanoparticles are prepared, which greatly increases their specific surface area, and the number of surface catalytic sites increases geometrically, significantly improving the catalytic activity of the nanozyme.

[0014] Furthermore, in step S1, the cationic surfactant is a hexadecyltrimethylammonium chloride aqueous solution with a concentration of 20 mM;

[0015] Further, in the HAuCl4 / K2PdCl6 mixed solution in step S1, the molar ratio of HAuCl4 and K2PdCl6 is 1:1, the concentration of HAuCl4 is 10 mM, and the concentration of K2PdCl6 is 10 mM;

[0016] Further, in step S1, the reducing agent is ascorbic acid solution with a concentration of 150 mM;

[0017] Furthermore, in step S1, the volume ratio of the cationic surfactant aqueous solution, the HAuCl4 / K2PdCl6 mixed solution and the reducing agent is 9.785:0.2:0.015.

[0018] Furthermore, in step S2, the aqueous solution of the polyethylene glycol modifier is an amino-polyethylene glycol-thiol aqueous solution with a concentration of 1 mg / mL; the molecular weight of the amino-polyethylene glycol-thiol is 2000.

[0019] It should be noted that when amino-polyethylene glycol-thiol with a molecular weight of 2000 is grafted onto gold-palladium alloy nanoparticles, the grafting density will be higher, and more amino groups can be introduced onto the surface of the gold-palladium alloy nanoparticles.

[0020] Furthermore, in step S2, the dosage ratio of gold-palladium alloy nanoparticle powder, deionized water, polyethylene glycol modifier aqueous solution, anhydrous ethanol and α-bromocinnamaldehyde is 10 mg: 10 mL: 10 mL: 10 mL: 21 mg.

[0021] It should be noted that cinnamaldehyde is a cinnamon extract with antibacterial and anti-inflammatory effects. As an α, β-unsaturated ketone, cinnamaldehyde can undergo Michael addition reaction with glutathione, thereby removing glutathione and improving the antibacterial / anti-cancer ability mediated by reactive oxygen. However, after cinnamaldehyde and glutathione with equal molar concentrations were placed for 4 hours, cinnamaldehyde could only remove 50% of glutathione. α-Bromocinnamaldehyde is a derivative of cinnamaldehyde. Due to the introduction of an electron-withdrawing Br group at the α position, it has stronger antibacterial and glutathione scavenging abilities. Therefore, α-Bromocinnamaldehyde can remove glutathione at a lower dose and faster rate than cinnamaldehyde, promoting nanozyme-mediated catalysis.

[0022] Furthermore, the dialysis operation in step S2 is: dialysis with a 2000Kda dialysis bag for 24 hours.

[0023] Furthermore, the gold-palladium alloy-loaded α-bromocinnamaldehyde nano-antibacterial agent is suitable for acidic environments, and with the assistance of mild photothermal effects, the sterilization and debridement effects are better.

[0024] It should be noted that when the gold-palladium alloy-loaded α-bromocinnamaldehyde nano-antibacterial agent enters the infected wound, on the one hand, the enzymatic activity of the peroxidase and oxidase of the gold-palladium alloy nanoparticles is activated under weak acid conditions, producing a large amount of reactive oxygen to eliminate bacteria. On the other hand, the acidic pH causes the acid-sensitive imine bond to break, releasing the loaded α-bromocinnamaldehyde to remove glutathione, which further enhances the oxidative stress of the nanozyme on bacteria. When the bacteria are killed, the pH of the infected wound gradually rises toward neutrality. At this time, the activity of peroxidase and oxidase is inhibited, and the catalase activity of the nanozyme is activated, which begins to remove hydrogen peroxide and produce oxygen to promote wound healing. In clinical applications, photothermal therapy can be used to promote the operation of its mechanism of action. The mild photothermal effect can be used as a switch. Under the irradiation of near-infrared light, the enzyme activity and drug release of the nanozyme can be further enhanced. Therefore, with the synergistic effect of the multi-enzyme activity of gold-palladium nanoparticles, mild photothermal effects, and the antibacterial and scavenging effects of α-bromocinnamaldehyde and glutathione, it can effectively eliminate bacteria and promote the healing of bacterially infected wounds.

[0025] Furthermore, the application scenarios of gold-palladium alloy-loaded α-bromocinnamaldehyde nano antibacterial agent in the field of antibacterial agents are as follows:

[0026] Added to epidermal sites and / or subcutaneous tissues of the human body infected with bacteria;

[0027] or added to the epidermal sites and / or subcutaneous tissue of bacterially infected animals;

[0028] Or coated on the surface of the material;

[0029] or coated on the surface of a material and added to the epidermal area and / or subcutaneous tissue of a human body infected with bacteria;

[0030] Alternatively, the material may be applied to the surface of the material and added to the epidermal area and / or subcutaneous tissue of an animal infected with the bacteria.

[0031] Compared with the prior art, the present invention has the following beneficial effects:

[0032] Multi-branched octapod-shaped gold-palladium alloy nanoparticles were synthesized by a seedless method, which greatly increased their specific surface area and increased the number of surface catalytic sites exponentially, significantly improving the catalytic activity of the nanozyme.

[0033] After the gold-palladium alloy-loaded α-bromocinnamaldehyde nano-antibacterial agent enters the infected wound in an acidic environment, it regulates the activation and inhibition of enzyme activity, the generation of ROS, the release of α-bromocinnamaldehyde, and the generation of oxygen by adjusting the changes in the environmental pH. The gold-palladium alloy-loaded α-bromocinnamaldehyde nano-antibacterial agent can synergize the multi-enzyme activity of gold-palladium alloy nanoparticles, mild photothermal effects, and the antibacterial effects and glutathione scavenging effects of α-bromocinnamaldehyde to effectively eliminate bacteria and promote the healing of bacterially infected wounds. BRIEF DESCRIPTION OF THE DRAWINGS

[0034] Figure 1 This is a scanning electron microscope image of gold-palladium alloy nanoparticles.

[0035] Figure 2 This is a transmission electron microscopy image of gold-palladium alloy nanoparticles (scale bar is 100 nm).

[0036] Figure 3 This is a transmission electron microscopy image of gold-palladium alloy nanoparticles (scale bar is 50 nm).

[0037] Figure 4 Actual photos of the removal of Escherichia coli after culture with the antibacterial solutions prepared in the examples of the present invention and the comparative examples.

[0038] Figure 5 This is a diagram of the antibacterial effects of the antibacterial solutions prepared in the examples and comparative examples of the present invention obtained using the bacterial plate counting method.

[0039] Figure 6 These are the photothermal performance test results of gold-palladium alloy nanoparticles.

[0040] Figure 6 (a) Absorbance of Au / Pd alloy nanoparticle dispersions with different concentrations under laser irradiation;

[0041] Figure 6 (b) Mass extinction coefficient of gold-palladium alloy nanoparticle dispersion under 808 nm laser irradiation;

[0042] Figure 6 (c) Temperature changes of gold-palladium alloy nanoparticle dispersions with different concentrations under 808 nm laser irradiation;

[0043] Figure 6 (d) Temperature change of gold-palladium alloy nanoparticle dispersion with a concentration of 100 μg / mL under 808 nm laser irradiation of different powers;

[0044] Figure 6 (e) The temperature change of the gold-palladium alloy nanoparticle dispersion with a concentration of 50 μg / mL was observed after 808 nm laser irradiation for 15 min and then cooled to ambient temperature. The cycle was repeated 5 times.

[0045] Figure 6 (f) Absorbance of the gold-palladium alloy nanoparticle dispersion after laser irradiation of 50 μg / mL gold-palladium alloy nanoparticle dispersion for 15 min and cooling to ambient temperature, and the cycle was repeated 5 times;

[0046] Figure 6 (g) Temperature change of a gold-palladium alloy nanoparticle dispersion with a concentration of 50 μg / mL after irradiation with 808 nm laser for 15 min and then cooled to ambient temperature;

[0047] Figure 6 (h) Photothermal conversion curve of a gold-palladium alloy nanoparticle dispersion with a concentration of 50 μg / mL after 808 nm laser irradiation for 10 min and then cooled to ambient temperature during the cooling stage.

[0048] Figure 7 The experimental results verify the enzyme-like activity of gold-palladium alloy nanoparticles.

[0049] Oxidase-like enzyme activity:

[0050] Figure 7 (a) Absorbance of different reaction systems at 500-800 nm;

[0051] Figure 7 (b) Absorbance at 500-800 nm for different material concentrations;

[0052] Figure 7 (c) Absorbance at 500-800 nm at different times.

[0053] Peroxidase Activity:

[0054] Figure 7 (d) absorbance at 500-800 nm for different material concentrations;

[0055] Figure 7(e) absorbance at 500-800 nm at different hydrogen peroxide concentrations;

[0056] Figure 7 (f) Absorbance at 500-800 nm at different times.

[0057] Catalase Activity:

[0058] Figure 7 (g) Oxygen bubble generation in different reaction systems.

[0059] Figure 8 These are the test results of the ability of cinnamaldehyde and different concentrations of α-bromocinnamaldehyde to consume glutathione.

[0060] Figure 8 (a) Experimental principle diagram;

[0061] Figure 8 (b) The effect of PBS solution, cinnamaldehyde and α-bromocinnamaldehyde on glutathione consumption after being placed for different time periods;

[0062] Figure 8 (c) Graph showing the effect of different concentrations of α-bromocinnamaldehyde on the consumption of glutathione. DETAILED DESCRIPTION

[0063] The following will be combined with the drawings in the embodiments of the present invention to clearly and completely describe the technical solutions in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0064] Example

[0065] S1. Preheat 9.785 mL of 20 mM hexadecyltrimethylammonium chloride aqueous solution at 70 °C for 10 min, add 0.2 mL of HAuCl4 / K2PdCl6 mixed solution, the concentration of HAuCl4 and K2PdCl6 is 10 mM respectively, and homogenize for 3 min; add 0.015 mL of 150 mM ascorbic acid solution, shake gently, and stand for reaction in a 70 °C water bath for 2 h, collect the lower precipitate by centrifugation at 10000 r / min, wash the collected material with deionized water 3 times, and vacuum dry to obtain a gold-palladium alloy nanoparticle powder sample;

[0066] S2. Disperse 10 mg of gold-palladium alloy nanoparticle powder sample in 10 mL of deionized water to obtain a gold-palladium alloy nanoparticle dispersion; slowly add 10 mL of 2000k amino-polyethylene glycol-thiol aqueous solution with a concentration of 1 mg / mL to the gold-palladium alloy nanoparticle dispersion, ultrasonicate for 30 min, stir at room temperature for 12 h, collect the lower precipitate by centrifugation at 13000 r / min, wash the collection three times with deionized water, and disperse it in 10 mL of anhydrous ethanol with a pH of 8-9, adjust the anhydrous ethanol with 0.1 mM sodium hydroxide, add 21 mg of α-bromocinnamaldehyde to the above solution under rapid stirring, react at 60°C for 12 h, dialyze with a 2000Kda dialysis bag for 24 h, wash three times with anhydrous ethanol, and collect the product by centrifugation to obtain a gold-palladium alloy-loaded α-bromocinnamaldehyde nano-antibacterial agent.

[0067] S3, gold-palladium alloy loaded α-bromocinnamaldehyde nano antibacterial agent and H2O2 were mixed evenly, the concentration of gold-palladium alloy loaded α-bromocinnamaldehyde nano antibacterial agent was 100ug / mL, and the concentration of H2O2 was 200×10 -6 M, use 1.5W / cm 2 Laser treatment for 15 min.

[0068] Comparative Example 1

[0069] S1. Preheat 9.785 mL of 20 mM hexadecyltrimethylammonium chloride aqueous solution at 70 °C for 10 min, add 0.2 mL of HAuCl4 / K2PdCl6 mixed solution, the concentration of HAuCl4 and K2PdCl6 is 10 mM respectively, and homogenize for 3 min; add 0.015 mL of 150 mM ascorbic acid solution, shake gently, and stand for reaction in a 70 °C water bath for 2 h, collect the lower precipitate by centrifugation at 10000 r / min, wash the collected material with deionized water 3 times, and vacuum dry to obtain a gold-palladium alloy nanoparticle powder sample;

[0070] S2. Disperse 10 mg of gold-palladium alloy nanoparticle powder sample in 10 mL of deionized water to obtain a gold-palladium alloy nanoparticle dispersion; slowly add 10 mL of 2000k amino-polyethylene glycol-thiol aqueous solution with a concentration of 1 mg / mL to the gold-palladium alloy nanoparticle dispersion, ultrasonicate for 30 min, stir at room temperature for 12 h, collect the lower precipitate by centrifugation at 13000 r / min, wash the collection three times with deionized water, and disperse it in 10 mL of anhydrous ethanol with a pH of 8-9, adjust the anhydrous ethanol with 0.1 mM sodium hydroxide, add 21 mg of α-bromocinnamaldehyde to the above solution under rapid stirring, react at 60°C for 12 h, dialyze with a 2000Kda dialysis bag for 24 h, wash three times with anhydrous ethanol, and collect the product by centrifugation to obtain a gold-palladium alloy-loaded α-bromocinnamaldehyde nano-antibacterial agent.

[0071] S3, gold-palladium alloy loaded α-bromocinnamaldehyde nano antibacterial agent and H2O2 were mixed evenly, the concentration of gold-palladium alloy loaded α-bromocinnamaldehyde nano antibacterial agent was 100ug / mL, and the concentration of H2O2 was 200×10 -6 M.

[0072] Comparative Example 2

[0073] S1. Preheat 9.785 mL of 20 mM hexadecyltrimethylammonium chloride aqueous solution at 70 °C for 10 min, add 0.2 mL of HAuCl4 / K2PdCl6 mixed solution, the concentration of HAuCl4 and K2PdCl6 is 10 mM respectively, and homogenize for 3 min; add 0.015 mL of 150 mM ascorbic acid solution, shake gently, and stand for reaction in a 70 °C water bath for 2 h, collect the lower precipitate by centrifugation at 10000 r / min, wash the collected material with deionized water 3 times, and vacuum dry to obtain a gold-palladium alloy nanoparticle powder sample;

[0074] S2, mix the gold-palladium alloy nanoparticle powder sample and H2O2 evenly, the concentration of gold-palladium alloy nanoparticles is 100ug / mL, and the concentration of H2O2 is 200×10 -6 M, use 1.5W / cm 2 Laser treatment for 15 min.

[0075] Comparative Example 3

[0076] S1. Preheat 9.785 mL of 20 mM hexadecyltrimethylammonium chloride aqueous solution at 70 °C for 10 min, add 0.2 mL of HAuCl4 / K2PdCl6 mixed solution, the concentration of HAuCl4 and K2PdCl6 is 10 mM respectively, and homogenize for 3 min; add 0.015 mL of 150 mM ascorbic acid solution, shake gently, and stand for reaction in a 70 °C water bath for 2 h, collect the lower precipitate by centrifugation at 10000 r / min, wash the collected material with deionized water 3 times, and vacuum dry to obtain a gold-palladium alloy nanoparticle powder sample;

[0077] S2, mix the gold-palladium alloy nanoparticle powder sample and H2O2 evenly, the concentration of gold-palladium alloy nanoparticles is 100ug / mL, and the concentration of H2O2 is 200×10 -6 M.

[0078] Comparative Example 4

[0079] Use 1.5W / cm 2 The laser was treated with PBS solution with a pH of 7.2-7.4 for 15 min.

[0080] Comparative Example 5

[0081] PBS solution with a pH of 7.2-7.4.

[0082] test:

[0083] 1. Antibacterial activity test

[0084] The antibacterial solution prepared above was mixed with 1×10 5 After incubation of E. coli with 100 CFU / mL on a shaker at 37 °C for 4 h, 100 μL of bacterial suspension was spread on an agar plate and incubated in a 37 °C bacterial incubator for 12 h. The number of colony forming units in each group was determined by the plate count method and counted using Image J software.

[0085] Depend on Figure 4 and Figure 5 It can be concluded that the gold-palladium alloy-loaded α-bromocinnamaldehyde nano-antibacterial agent can effectively kill Escherichia coli under the action of near-infrared light and heat. The examples are experimental results of the present invention.

[0086] 2. Photothermal performance test

[0087] Firstly, the spectra of gold-palladium alloy nanoparticle solutions with different concentrations of 10, 30, 50, 70, and 90 μg / mL were measured by the sweep mode of the UV spectrophotometer, and their absorbance at 808 nm was calculated to calculate their mass extinction coefficient.

[0088] To evaluate the photothermal properties of AuPd alloy nanoparticles, the temperature difference caused by near-infrared laser irradiation of different solutions was recorded every 30 seconds, and a graph was plotted according to the irradiation duration. 2 The uniform concentration of gold-palladium alloy nanoparticle dispersion was irradiated with a 808nm laser of 1.5W / cm 2 The gold-palladium alloy nanoparticle dispersions with concentrations of 0, 10, 25, 50, 75, and 100 μg / mL were irradiated with an 808 nm laser of high power for 15 min, and the temperature change was monitored simultaneously.

[0089] To evaluate the photothermal stability of the nanosystem, a 50 μg / mL gold-palladium alloy nanoparticle dispersion was placed under 808 nm laser irradiation for 15 min and then allowed to cool to ambient temperature. This on / off cycle was repeated 5 times, and the temperature change of the solution was continuously recorded throughout the process, and the photothermal conversion rate was calculated from the curve of its cooling stage.

[0090] Depend on Figure 6 The conclusions can be drawn:

[0091] Figure 6(a) shows that the absorbance of gold-palladium alloy nanoparticles is positively correlated with their concentration;

[0092] Figure 6 (b) shows that the mass extinction coefficient of gold-palladium alloy at 808 nm is 5.26 L / (g·cm), indicating that gold-palladium alloy has excellent light absorption ability at this wavelength;

[0093] Figure 6 (c) shows that the temperature is higher and the heating rate is faster when the concentration of gold-palladium alloy nanoparticles is 100 μg / mL under 808 nm laser irradiation, and it tends to stabilize faster;

[0094] Figure 6 (d) indicates that the power is 2.0 W / cm 2 When irradiated with 808nm laser, the temperature is higher and the heating rate is faster;

[0095] Figure 6 (e) shows that after 5 rounds of heating and cooling (laser on and off), the highest temperature that can be reached remains almost unchanged, indicating that the photothermal stability of the gold-palladium alloy is good;

[0096] Figure 6 (f) shows that the UV spectrum of the gold-palladium alloy has almost no change before and after laser irradiation, indicating that the gold-palladium alloy has good thermal stability;

[0097] Figure 6 (g) and (h) show that the photothermal conversion capacity of gold-palladium alloy nanoparticles is 32.96%, which is better than some traditional photothermal agents and is suitable for photothermal therapy.

[0098] 3. Enzyme Activity Verification Experiment

[0099] The POD-like and OXD-like enzyme activities of gold-palladium alloy nanoparticles were studied by the classic TMB reaction.

[0100] For the verification of oxidase (OXD)-like activity, the entire reaction system is: 2mL of 20mM acetate buffer, pH 4.0, TMB with a final concentration of 1mM and gold-palladium alloy nanoparticles with a final concentration of 100μg / mL. The reaction system was mixed and incubated at room temperature for 10min, and then the data was recorded by the 500-800nm ​​wave scanning mode of the UV spectrophotometer, focusing on its absorbance at 652nm. In addition, the OXD-like enzyme activity was tested at different material concentrations and different times.

[0101] For the verification of peroxidase (POD)-like activity, the entire reaction system is: 2mL of 20mM acetate buffer at pH 4.0, TMB at a final concentration of 1mM, H2O2 at a final concentration of 1mM, and gold-palladium alloy nanoparticles at a final concentration of 100μg / mL. The reaction system was mixed and incubated at room temperature for 10min, and then the data was recorded by the 500-800nm ​​wave scanning mode of the UV spectrophotometer, focusing on its absorbance at 652nm. In addition, the POD-like enzyme activity was tested at different material concentrations, different substrate concentrations, and different times.

[0102] For the validation of catalase (CAT)-like activity, the entire reaction system was: 2 mL of 1X PBS buffer with a pH of 7.2-7.4, H2O2 with a final concentration of 100 mM, and gold-palladium alloy nanoparticles with a final concentration of 100 μg / mL. The reaction system was mixed and incubated at room temperature for 10 minutes, and the number of oxygen bubbles generated was observed.

[0103] Depend on Figure 7 The conclusions can be drawn:

[0104] Figure 7 (a) The verification of enzyme-like activity shows that the gold-palladium alloy has both obvious peroxidase and oxidase-like activities;

[0105] Figure 7 (b) and (d) The verification of enzyme-like activity showed that the enzyme activity of oxidase and peroxidase was the highest when the concentration of gold-palladium alloy nanoparticles was 100 μg / mL;

[0106] Figure 7 (c) and (f) The verification of enzyme-like activity showed that the enzyme activity of oxidase and peroxidase was the highest at 652 nm when the reaction time was 30 min;

[0107] Figure 7 (e) The verification of enzyme-like activity showed that as the concentration of hydrogen peroxide increased, the peroxidase-like activity gradually increased.

[0108] Figure 7 (g) The validation of catalase-like activity showed that under neutral conditions, gold-palladium alloy can effectively catalyze hydrogen peroxide into oxygen.

[0109] 4. Glutathione consumption capacity test

[0110] The glutathione consumption capacity of cinnamaldehyde and α-bromocinnamaldehyde was compared using the DTNB experiment. The entire reaction system was: 500 μL of PBS solution with a pH of 7.2-7.4, a final concentration of 1 mM glutathione and 1 mM cinnamaldehyde or α-bromocinnamaldehyde. After mixing, the mixture was placed at room temperature for 30 min, 1 h, 2 h, and 4 h, 20 μL of the reaction solution was extracted and added to 180 μL of DTNB solution with a final concentration of 0.02 mM DTNB. The reaction lasted for 5 min, and the absorbance at 412 nm was measured by an ELISA reader.

[0111] The glutathione consumption capacity of different concentrations of α-bromocinnamaldehyde was tested. The entire reaction system was: 500ul PBS solution with a pH of 7.2-7.4, a final concentration of 1mM glutathione and final concentrations of 1mM, 0.5mM, 0.25mM, 0.125mM, 0.0625mM, and 0.03125mM α-bromocinnamaldehyde, mixed and placed at room temperature for 30min. 20μL of the reaction solution was extracted and added to the DTNB solution with a final concentration of 0.02mM DTNB. The reaction was continued for 5min, and the absorbance at 412nm was tested by an ELISA reader.

[0112] Depend on Figure 8 The conclusions can be drawn:

[0113] Figure 8 (b) It shows that the ability of α-bromocinnamaldehyde to consume glutathione is stronger than that of cinnamaldehyde;

[0114] Figure 8 (c) shows that when the molar ratio of α-bromocinnamaldehyde to glutathione is 1:1, the consumption of glutathione is the highest and the clearance rate is close to 100%.

[0115] Although embodiments of the present invention have been shown and described, it will be appreciated by those skilled in the art that various changes, modifications, substitutions and variations may be made to the embodiments without departing from the principles and spirit of the present invention, and that the scope of the present invention is defined by the appended claims and their equivalents.

Claims

1. A preparation method of a gold-palladium alloy-loaded α-bromocinnamaldehyde nano antibacterial agent, characterized in that: The specific steps are as follows: S1. Preheat the cationic surfactant aqueous solution at 70°C for 10 minutes, add the HAuCl4 / K2PdCl6 mixed solution, and homogenize for 3 minutes; add the reducing agent, and let it stand for reaction in a 70°C water bath for 2 hours. After the reaction is completed, centrifuge, wash with deionized water, and vacuum dry to obtain a gold-palladium alloy nanoparticle powder sample; S2. Disperse the gold-palladium alloy nanoparticle powder sample in deionized water to obtain a gold-palladium alloy nanoparticle dispersion; slowly add the polyethylene glycol modifier aqueous solution to the gold-palladium alloy nanoparticle dispersion, ultrasonicate for 30 minutes, stir at room temperature for 12 hours, collect the lower precipitate by centrifugation, wash the precipitate with deionized water, disperse the precipitate in anhydrous ethanol with a pH of 8-9, add α-bromocinnamaldehyde while stirring, react at 60°C for 12 hours, dialyze, wash and centrifuge to obtain a gold-palladium alloy-loaded α-bromocinnamaldehyde nano-antibacterial agent.

2. The preparation of gold-palladium alloy nanoparticles according to claim 1, characterized in that: The gold-palladium alloy nanoparticles are in an octapod shape with a large specific surface area, and the particle size of the gold-palladium alloy nanoparticles is 60-80nm.

3. The preparation of a gold-palladium alloy-loaded α-bromocinnamaldehyde nano antibacterial agent according to claim 1, characterized in that: In step S1, the cationic surfactant is a hexadecyltrimethylammonium chloride aqueous solution with a concentration of 20 mM.

4. The preparation of a gold-palladium alloy-loaded α-bromocinnamaldehyde nano antibacterial agent according to claim 1, characterized in that: In step S1, the molar ratio of HAuCl4 and K2PdCl6 in the HAuCl4 / K2PdCl6 mixed solution is 1:1, the concentration of HAuCl4 is 10 mM, and the concentration of K2PdCl6 is 10 mM.

5. The preparation of a gold-palladium alloy-loaded α-bromocinnamaldehyde nano antibacterial agent according to claim 1, characterized in that: In step S1, the reducing agent is ascorbic acid solution with a concentration of 150 mM.

6. The preparation of a gold-palladium alloy-loaded α-bromocinnamaldehyde nano antibacterial agent according to claim 1, characterized in that: In step S1, the volume ratio of the cationic surfactant aqueous solution, the HAuCl4 / K2PdCl6 mixed solution and the reducing agent is 9.785:0.2:0.

015.

7. The preparation of a gold-palladium alloy-loaded α-bromocinnamaldehyde nano antibacterial agent according to claim 1, characterized in that: The aqueous solution of the polyethylene glycol modifier in step S2 is an amino-polyethylene glycol-thiol aqueous solution with a concentration of 1 mg / mL; the molecular weight of the amino-polyethylene glycol-thiol is 2000.

8. The preparation of a gold-palladium alloy-loaded α-bromocinnamaldehyde nano antibacterial agent according to claim 1, characterized in that: In step S2, the dosage ratio of gold-palladium alloy nanoparticle powder, deionized water, polyethylene glycol modifier aqueous solution, anhydrous ethanol and α-bromocinnamaldehyde is 10 mg: 10 mL: 10 mL: 10 mL: 21 mg.

9. The preparation of a gold-palladium alloy-loaded α-bromocinnamaldehyde nano antibacterial agent according to claim 1, characterized in that: The dialysis operation in step S2 is: dialysis for 24 hours using a 2000Kda dialysis bag.